Date published: 2026-3-17

1-800-457-3801

SCBT Portrait Logo
Seach Input

Smad8 Activators

Smad8, a pivotal member of the Smad family proteins, plays a critical role in transducing signals from the cell membrane to the nucleus, predominantly within the transforming growth factor-beta (TGF-β) signaling pathway. As an essential component of this pathway, Smad8 functions as a receptor-regulated Smad (R-Smad), which becomes phosphorylated upon activation of the type I TGF-β receptor by ligand binding. This phosphorylation event triggers the formation of complexes between Smad8 and Smad4, facilitating their translocation into the nucleus. Once in the nucleus, Smad8 complexes with various transcription factors and co-factors, ultimately modulating the expression of target genes implicated in diverse cellular processes such as cell proliferation, differentiation, and apoptosis. The multifaceted functions of Smad8 underscore its significance in orchestrating crucial cellular responses and maintaining tissue homeostasis.

Activation of Smad8 is initiated by the binding of TGF-β ligands to their cognate receptors on the cell surface, triggering a cascade of intracellular events. Upon ligand binding, the type II TGF-β receptor phosphorylates and activates the type I receptor, which subsequently phosphorylates Smad8 at specific serine residues. Phosphorylated Smad8 then forms heteromeric complexes with Smad4, leading to their translocation into the nucleus and subsequent regulation of target gene expression. Additionally, various regulatory proteins, including Smad6 and Smad7, modulate Smad8 activation by fine-tuning the intensity and duration of TGF-β signaling through feedback mechanisms. Overall, the activation of Smad8 represents a tightly regulated process governed by a series of molecular events within the TGF-β signaling pathway, highlighting its pivotal role in mediating cellular responses to extracellular stimuli.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

4-(6-(4-(Piperazin-1-yl)phenyl)pyrazolo[1,5-a]pyrimidin-3-yl)quinoline

1062368-24-4sc-476297
5 mg
$240.00
(0)

LDN-193189 is a small molecule that acts as a direct inhibitor of BMP type I receptors. By blocking the BMP signaling pathway at the receptor level, LDN-193189 prevents the inhibitory effects on Smad8 activation, indirectly promoting Smad8 phosphorylation and nuclear translocation.

DMH-1

1206711-16-1sc-361171
sc-361171B
sc-361171A
sc-361171C
10 mg
25 mg
50 mg
100 mg
$213.00
$318.00
$632.00
$1047.00
2
(0)

DMH1 is a selective BMP receptor inhibitor that indirectly activates Smad8. Through the inhibition of BMP signaling, DMH1 disrupts the negative regulation on Smad8 activation, leading to increased phosphorylation and nuclear translocation of Smad8.

Dorsomorphin dihydrochloride

1219168-18-9sc-361173
sc-361173A
10 mg
50 mg
$186.00
$751.00
28
(2)

Dorsomorphin is a compound that inhibits AMP-activated protein kinase (AMPK) and BMP signaling. Through its impact on BMP signaling, dorsomorphin indirectly activates Smad8 by relieving the inhibitory constraints on Smad8 phosphorylation and nuclear translocation.

5-[6-[4-(1-Piperazinyl)phenyl]pyrazolo[1,5-a]pyrimidin-3-yl]quinoline

1432597-26-6sc-476318
5 mg
$380.00
(0)

LDN-212854 is a potent and selective BMP receptor inhibitor that indirectly activates Smad8. By inhibiting BMP signaling, LDN-212854 disrupts the negative regulation on Smad8 activation, leading to increased phosphorylation and nuclear translocation of Smad8.